Impact of Insulin care and administration reinforcement education ICARE through WhatsApp messages on glycemic control among diabetes patients using insulin, attending Endocrinology OPD of a tertiary care center in Eastern India, A single blind placebo controlled parallel group block randomized trial. - NI

AIIMS Kalyani0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.All consecutive patients attending the Endocrinology and Metabolism Outpatient Department of AIIMS, Kalyani, with a known history of Diabetes Mellitus who are on insulin therapy for minimum span of 3 months.
•2.Age group: 30-50 yrs
•3.BMI: 23-30 kg/m2
•4.Patients having HbA1c level: 7.5-12.5%
•5.Patients receiving Insulin at least twice a day
•6.Patients who has access to WhatsApp.

•1.Patients with known psychiatric illness and/or currently on psychiatry medications.
•2.Any underlying Endocrinological disorder causing secondary diabetes mellitus such as Cushing’s disease, Acromegaly, Hyperthyroidism, type 3c diabetes.
•3.Patients having secondary diabetes related to drugs like steroids, chemotherapy etc.
•4.Pregnant and lactating mother up to 6 months, patients suffering from cancer and/or had a history of radiation or chemotherapy
•5.DM Patients with CLD, CKD, eGFR less than 15, heart failure, any hematological disorder like beta-thalassemia etc.

发起方